ITHACA — Rheonix Inc., of Ithaca, which created an early rapid-turnaround COVID-19 test during the coronavirus pandemic, has opened a new laboratory, Rheonix Laboratories LLC, a CLIA-certified clinical laboratory located in Ithaca.
Rheonix Laboratories is permitted by New York state to provide COVID-19 PCR testing and results, and will partner with pharmacies, schools, long-term care facilities and county and municipal health departments to provide low-cost testing to their populations.
It will use its trademarked assay, which was first granted emergency use authorization by the U.S. Food and Drug Administration in April 2020. The assay is highly sensitive and detects all COVID-19 variants of concern, including the Omicron subvariants. Results are expected within 24 hours after receipt of sample.
"Offering testing through an affiliated laboratory is an important extension of Rheonix's core mission: to offer molecular diagnostics to more people, in more places, more often," said Greg Galvin, Rheonix's president, CEO and chairman. "The initial focus of Rheonix Laboratories is to provide a convenient and economical COVID-19 PCR testing option for organizations and community members. In the future, we plan to offer additional assays at the laboratory, including syndromic panels for respiratory, gastrointestinal and sexually transmitted infections."
For details or to schedule a COVID-19 test, go to rheonixlabs.com.
